• Caeli Nova

  Led · Series A · Jan 2022

  Caeli Nova develops patented breathing technology aimed at improving human safety and performance, principally through its launch product Cordillera, an advanced aircraft emergency oxygen system. Cordillera is designed to overcome limitations of existing aircraft oxygen systems, improve oxygenation at altitude, and enable airlines to fly more direct routes, reducing costs and carbon emissions. The company was founded in 2018 and operates from offices in the UK and Switzerland with a team of 40 medical and aerospace specialists. Caeli Nova aims to install Cordillera onto its first aircraft during 2022 and will use the new financing to further enhance the technology. The startup also intends to explore applications of its breathing technology in clinical and hospital settings. Financially, the company has closed a €7.7 million Series A to advance product development and initial market installations.

• Liom

  Led · Equity · Apr 2021

  Founded in 2017 in Schwyz, Liom (formerly Spiden) is building a wearable that measures glucose non-invasively using a miniaturised Raman spectroscopy platform. The technology achieves 12× higher light throughput than lab-scale devices, enabling smartwatch-sized hardware with more than 24-hour battery life. Liom has already demonstrated calibration-free glucose measurement on over 130 subjects and plans to launch its first commercial product in 2028. The company positions its device as a breakthrough over existing continuous glucose monitors that rely on microneedles, targeting mass-market adoption among consumers and athletes. Recent progress shifts the firm from pure R&D toward product development and commercialisation, supported by new board member and investor Marc Maurer, former co-CEO of On Running. To date, Liom has raised €67.6 million in venture funding, giving it resources to scale manufacturing and prepare for regulatory and market entry.

No current team members are available.